Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Operating Margin
Jiangsu Bioperfectus Technologies Co Ltd
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| CN |
|
Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
|
4B CNY |
-17%
|
|
| CH |
|
Alcon AG
SIX:ALC
|
36.2B CHF |
14%
|
|
| JP |
|
Hoya Corp
TSE:7741
|
6T JPY |
29%
|
|
| DK |
|
Coloplast A/S
CSE:COLO B
|
146B DKK |
27%
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.7B USD |
17%
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.6B GBP |
15%
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
44.9B CNY |
43%
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
5.1B CHF |
14%
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
5.7B USD |
12%
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.2B USD |
29%
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
6.9T KRW |
-149%
|
Jiangsu Bioperfectus Technologies Co Ltd
Glance View
Jiangsu Bioperfectus Technologies Co., Ltd. engages in the research, development, production, and sale of in vitro diagnostic reagents and supporting testing instruments. The company is headquartered in Taizhou, Jiangsu and currently employs 765 full-time employees. The company went IPO on 2019-12-05. The firm's products mainly include in vitro diagnostic reagents, supporting testing instruments and in vitro testing services. Its products are mainly used in the fields of infectious disease prevention and control, clinical testing, large-scale population screening, as well as prenatal and postnatal care management. The firm mainly conducts its businesses in domestic and overseas markets.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Jiangsu Bioperfectus Technologies Co Ltd's most recent financial statements, the company has Operating Margin of -17%.
You don't have any saved screeners yet